{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:50:54Z","timestamp":1784728254865,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404171"],"award-info":[{"award-number":["82404171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09048-z","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:10:23Z","timestamp":1744215023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epigenetic Modifications in Vitiligo"],"prefix":"10.1007","volume":"68","author":[{"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"3","key":"9048_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li S, Li C (2021) Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin Rev Allergy Immunol 61(3):299\u2013323","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"9048_CR2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A et al (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16(3):208\u2013214","journal-title":"Pigment Cell Res"},{"issue":"5","key":"9048_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-20-0049","volume":"182","author":"J Skov","year":"2020","unstructured":"Skov J et al (2020) Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study. Eur J Endocrinol 182(5):473\u2013480","journal-title":"Eur J Endocrinol"},{"issue":"20","key":"9048_CR4","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.3390\/ijms21207571","volume":"21","author":"P Peixoto","year":"2020","unstructured":"Peixoto P et al (2020) From 1957 to nowadays: a brief history of epigenetics. Int J Mol Sci. 21(20):7571","journal-title":"Int J Mol Sci."},{"key":"9048_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lu Q, Chang C (2020) Epigenetics in health and disease. Adv Exp Med Biol 1253:3\u201355","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"9048_CR6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12016-022-08956-8","volume":"63","author":"F Gibson","year":"2022","unstructured":"Gibson F et al (2022) Epigenetic dysregulation in autoimmune and inflammatory skin diseases. Clin Rev Allergy Immunol 63(3):447\u2013471","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"9048_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K et al (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211\u2013232","journal-title":"Nat Rev Genet"},{"issue":"1","key":"9048_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC et al (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92\u2013105","journal-title":"Genome Res"},{"issue":"3","key":"9048_CR9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/pcmr.12086","volume":"26","author":"YL Shi","year":"2013","unstructured":"Shi YL et al (2013) MicroRNA expression profiling identifies potential serum biomarkers for non-segmental vitiligo. Pigment Cell Melanoma Res 26(3):418\u2013421","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"9048_CR10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bjd.13109","volume":"171","author":"MS Mansuri","year":"2014","unstructured":"Mansuri MS et al (2014) MicroRNA profiling reveals differentially expressed microRNA signatures from the skin of patients with nonsegmental vitiligo. Br J Dermatol 171(5):1263\u20131267","journal-title":"Br J Dermatol"},{"issue":"2","key":"9048_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1346-8138.12725","volume":"42","author":"Y Wang","year":"2015","unstructured":"Wang Y et al (2015) Differential expression analysis of miRNA in peripheral blood mononuclear cells of patients with non-segmental vitiligo. J Dermatol 42(2):193\u2013197","journal-title":"J Dermatol"},{"issue":"18","key":"9048_CR12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1101\/gad.17446611","volume":"25","author":"MN Cabili","year":"2011","unstructured":"Cabili MN et al (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25(18):1915\u20131927","journal-title":"Genes Dev"},{"issue":"3","key":"9048_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/pcmr.12081","volume":"26","author":"Y Huang","year":"2013","unstructured":"Huang Y et al (2013) A single-nucleotide polymorphism of miR-196a-2 and vitiligo: an association study and functional analysis in a Han Chinese population. Pigment Cell Melanoma Res 26(3):338\u2013347","journal-title":"Pigment Cell Melanoma Res"},{"issue":"12","key":"9048_CR14","volume":"9","author":"W Wang","year":"2023","unstructured":"Wang W et al (2023) Identification of the role of autophagy-related TNFSF10\/ hsa-let-7a-5p axis in vitiligo development and potential herbs exploring based on a bioinformatics analysis. Heliyon 9(12):e23220","journal-title":"Heliyon"},{"issue":"2","key":"9048_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ijd.15669","volume":"61","author":"M Alhelf","year":"2022","unstructured":"Alhelf M et al (2022) Association between long noncoding RNA taurine-upregulated gene 1 and microRNA-377 in vitiligo. Int J Dermatol 61(2):199\u2013207","journal-title":"Int J Dermatol"},{"issue":"21","key":"9048_CR16","volume":"38","author":"X Nie","year":"2024","unstructured":"Nie X et al (2024) FOXO3 induces TUG1-mediated miR-375\/GATA3 signaling axis to promote the survival of melanocytes in vitiligo. Faseb j 38(21):e70145","journal-title":"Faseb j"},{"key":"9048_CR17","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J et al (2022) Differentially expressed circular RNAs and their therapeutic mechanism in non-segmental vitiligo patients treated with methylprednisolone. Front Med (Lausanne) 9:839066","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"9048_CR18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/ijms17071144","volume":"17","author":"SA D\u2019Mello","year":"2016","unstructured":"D\u2019Mello SA et al (2016) Signaling pathways in melanogenesis. Int J Mol Sci 17(7):1144","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9048_CR19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/pcmr.12179","volume":"27","author":"KH Kim","year":"2014","unstructured":"Kim KH et al (2014) Novel inhibitory function of miR-125b in melanogenesis. Pigment Cell Melanoma Res 27(1):140\u2013144","journal-title":"Pigment Cell Melanoma Res"},{"key":"9048_CR20","first-page":"6832680","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X et al (2022) Study on the mechanism of miR-125b-5p affecting melanocyte biological behavior and melanogenesis in vitiligo through regulation of MITF. Dis Markers 2022:6832680","journal-title":"Dis Markers"},{"issue":"1","key":"9048_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yexcr.2013.09.017","volume":"320","author":"J Yang","year":"2014","unstructured":"Yang J et al (2014) BMP4 is required for the initial expression of MITF in melanocyte precursor differentiation from embryonic stem cells. Exp Cell Res 320(1):54\u201361","journal-title":"Exp Cell Res"},{"issue":"12","key":"9048_CR22","first-page":"2706","volume":"51","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022) Peripheral blood of vitiligo patients-derived exosomal MiR-21-5p inhibits melanocytes melanogenesis via targeting SATB1. Iran J Public Health 51(12):2706\u20132716","journal-title":"Iran J Public Health"},{"issue":"1","key":"9048_CR23","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1038\/s41598-019-46529-6","volume":"9","author":"U Vaish","year":"2019","unstructured":"Vaish U et al (2019) Micro RNAs upregulated in vitiligo skin play an important role in its aetiopathogenesis by altering TRP1 expression and keratinocyte-melanocytes cross-talk. Sci Rep 9(1):10079","journal-title":"Sci Rep"},{"issue":"5","key":"9048_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s10038-021-00993-z","volume":"67","author":"K Pang","year":"2022","unstructured":"Pang K et al (2022) LncRNA-mRNA co-expression network revealing the regulatory roles of lncRNAs in melanogenesis in vitiligo. J Hum Genet 67(5):247\u2013252","journal-title":"J Hum Genet"},{"issue":"2","key":"9048_CR25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jid.2023.08.019","volume":"144","author":"J Dong","year":"2024","unstructured":"Dong J et al (2024) Long non-coding RNA Mir17hg positively regulates melanogenesis by inhibiting TGF\u03b2 receptor 2 under psychological stress. J Invest Dermatol 144(2):358-368.e10","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9048_CR26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/path.6321","volume":"264","author":"F Yang","year":"2024","unstructured":"Yang F et al (2024) Disorganisation of basement membrane zone architecture impairs melanocyte residence in vitiligo. J Pathol 264(1):30\u201341","journal-title":"J Pathol"},{"issue":"3","key":"9048_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/JD9.0000000000000128","volume":"4","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang R-Z (2021) Mobilization of melanocytes during NB-UVB treatment of vitiligo. International Journal of Dermatology and Venereology 4(3):163\u2013167","journal-title":"International Journal of Dermatology and Venereology"},{"issue":"4","key":"9048_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/exd.12641","volume":"24","author":"RG Tarl\u00e9","year":"2015","unstructured":"Tarl\u00e9 RG et al (2015) Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo. Exp Dermatol 24(4):300\u2013302","journal-title":"Exp Dermatol"},{"issue":"1","key":"9048_CR29","volume":"384","author":"M Su","year":"2019","unstructured":"Su M et al (2019) miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment. Exp Cell Res 384(1):111615","journal-title":"Exp Cell Res"},{"issue":"4","key":"9048_CR30","first-page":"1017","volume":"45","author":"M Su","year":"2020","unstructured":"Su M et al (2020) Role of the p53-TRPM1\/miR-211-MMP9 axis in UVB-induced human melanocyte migration and its potential in repigmentation. Int J Mol Med 45(4):1017\u20131026","journal-title":"Int J Mol Med"},{"issue":"1","key":"9048_CR31","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1038\/s41598-022-17770-3","volume":"12","author":"HY Abdallah","year":"2022","unstructured":"Abdallah HY et al (2022) Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo. Sci Rep 12(1):13526","journal-title":"Sci Rep"},{"key":"9048_CR32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2147\/CCID.S372112","volume":"15","author":"H Luo","year":"2022","unstructured":"Luo H et al (2022) Differential expression of serum exosomal Hsa-miR-487b-3p in progressive vitiligo before and after systemic corticosteroid treatment. Clin Cosmet Investig Dermatol 15:1377\u20131386","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"9048_CR33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.biopha.2017.05.095","volume":"92","author":"S Patel","year":"2017","unstructured":"Patel S et al (2017) A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors. Biomed Pharmacother 92:501\u2013508","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"9048_CR34","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.imbio.2016.07.008","volume":"221","author":"Y Wang","year":"2016","unstructured":"Wang Y et al (2016) Downregulation of miR-3940-5p promotes T-cell activity by targeting the cytokine receptor IL-2R gamma on human cutaneous T-cell lines. Immunobiology 221(12):1378\u20131381","journal-title":"Immunobiology"},{"issue":"3","key":"9048_CR35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","volume":"57","author":"AN Shouse","year":"2024","unstructured":"Shouse AN, LaPorte KM, Malek TR (2024) Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer. Immunity 57(3):414\u2013428","journal-title":"Immunity"},{"issue":"1","key":"9048_CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/bjd.18890","volume":"183","author":"AS Parihar","year":"2020","unstructured":"Parihar AS et al (2020) Effect of narrowband ultraviolet B treatment on microRNA expression in active nonsegmental generalized vitiligo. Br J Dermatol 183(1):167\u2013169","journal-title":"Br J Dermatol"},{"issue":"1","key":"9048_CR37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41598-024-83489-y","volume":"15","author":"OG Shaker","year":"2025","unstructured":"Shaker OG et al (2025) Role of miR-16, 146a, 19b and 720 gene expressions in the pathogenesis and diagnosis of vitiligo. Sci Rep 15(1):1031","journal-title":"Sci Rep"},{"issue":"10","key":"9048_CR38","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/jcmm.12882","volume":"20","author":"X Jia","year":"2016","unstructured":"Jia X et al (2016) MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation. J Cell Mol Med 20(10):1898\u20131907","journal-title":"J Cell Mol Med"},{"issue":"3","key":"9048_CR39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40291-023-00646-1","volume":"27","author":"HY Abdallah","year":"2023","unstructured":"Abdallah HY et al (2023) Expression signature of immune-related microRNAs in autoimmune skin disease: psoriasis and vitiligo insights. Mol Diagn Ther 27(3):405\u2013423","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"9048_CR40","first-page":"3617","volume":"20","author":"M Lv","year":"2019","unstructured":"Lv M et al (2019) MicroRNA-155 inhibits the proliferation of CD8+ T cells via upregulating regulatory T cells in vitiligo. Mol Med Rep 20(4):3617\u20133624","journal-title":"Mol Med Rep"},{"key":"9048_CR41","doi-asserted-by":"publisher","unstructured":"Huo J et al (2021) MicroRNA\u201121\u20115p protects melanocytes via targeting STAT3 and modulating Treg\/Teff balance to alleviate vitiligo. Mol Med Rep 23(1). https:\/\/doi.org\/10.3892\/mmr.2020.11689","DOI":"10.3892\/mmr.2020.11689"},{"issue":"8","key":"9048_CR42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1468-3083.2008.02681.x","volume":"22","author":"PY Basak","year":"2008","unstructured":"Basak PY et al (2008) Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study. J Eur Acad Dermatol Venereol 22(8):970\u2013976","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"9048_CR43","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","volume":"10","author":"MK Tulic","year":"2019","unstructured":"Tulic MK et al (2019) Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun 10(1):2178","journal-title":"Nat Commun"},{"issue":"12","key":"9048_CR44","volume":"7","author":"R Yu","year":"2012","unstructured":"Yu R et al (2012) Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS ONE 7(12):e51040","journal-title":"PLoS ONE"},{"issue":"2","key":"9048_CR45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdermsci.2023.12.006","volume":"113","author":"Y Wei","year":"2024","unstructured":"Wei Y et al (2024) Exosomes containing miR-1469 regulate natural killer cells by targeting CD122 in non-segmental vitiligo. J Dermatol Sci 113(2):42\u201350","journal-title":"J Dermatol Sci"},{"issue":"31","key":"9048_CR46","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","volume":"11","author":"Q Wang","year":"2024","unstructured":"Wang Q et al (2024) 3D-hUMSCs exosomes ameliorate vitiligo by simultaneously potentiating Treg cells-mediated immunosuppression and suppressing oxidative stress-induced melanocyte damage. Adv Sci (Weinh) 11(31):e2404064","journal-title":"Adv Sci (Weinh)"},{"key":"9048_CR47","first-page":"2440377","volume":"2023","author":"NS Lai","year":"2023","unstructured":"Lai NS et al (2023) Increased expression of long noncoding RNA LOC100506314 in T cells from patients with nonsegmental vitiligo and its contribution to vitiligo pathogenesis. Mediators Inflamm 2023:2440377","journal-title":"Mediators Inflamm"},{"issue":"16","key":"9048_CR48","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","volume":"9","author":"TH Bestor","year":"2000","unstructured":"Bestor TH (2000) The DNA methyltransferases of mammals. Hum Mol Genet 9(16):2395\u20132402","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9048_CR49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7150\/ijbs.11218","volume":"11","author":"H Meng","year":"2015","unstructured":"Meng H et al (2015) DNA methylation, its mediators and genome integrity. Int J Biol Sci 11(5):604\u2013617","journal-title":"Int J Biol Sci"},{"issue":"5","key":"9048_CR50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","volume":"15","author":"PP Lee","year":"2001","unstructured":"Lee PP et al (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15(5):763\u2013774","journal-title":"Immunity"},{"issue":"5","key":"9048_CR51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri.2017.146","volume":"18","author":"AN Henning","year":"2018","unstructured":"Henning AN, Roychoudhuri R, Restifo NP (2018) Epigenetic control of CD8(+) T cell differentiation. Nat Rev Immunol 18(5):340\u2013356","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"9048_CR52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00439-023-02630-5","volume":"143","author":"L Liu","year":"2024","unstructured":"Liu L et al (2024) Genome-wide DNA methylation of lesional and peri-lesional skin in vitiligo: a comparative and integrated analysis of multi-omics in Chinese population. Hum Genet 143(2):137\u2013149","journal-title":"Hum Genet"},{"key":"9048_CR53","volume":"12","author":"Y Pu","year":"2021","unstructured":"Pu Y et al (2021) Transcriptome and differential methylation integration analysis identified important differential methylation annotation genes and functional epigenetic modules related to vitiligo. Front Immunol 12:587440","journal-title":"Front Immunol"},{"issue":"2","key":"9048_CR54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/clin.1996.0169","volume":"81","author":"GP Sreekumar","year":"1996","unstructured":"Sreekumar GP, Erf GF, Smyth JR Jr (1996) 5-Azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo. Clin Immunol Immunopathol 81(2):136\u2013144","journal-title":"Clin Immunol Immunopathol"},{"issue":"4","key":"9048_CR55","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2133.2010.09919.x","volume":"163","author":"M Zhao","year":"2010","unstructured":"Zhao M et al (2010) Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo. Br J Dermatol 163(4):736\u2013742","journal-title":"Br J Dermatol"},{"key":"9048_CR56","first-page":"2503924","volume":"2019","author":"Q Deng","year":"2019","unstructured":"Deng Q et al (2019) Transcriptome analysis and emerging driver identification of CD8+ T cells in patients with vitiligo. Oxid Med Cell Longev 2019:2503924","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"9048_CR57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","volume":"9","author":"X Meng","year":"2018","unstructured":"Meng X et al (2018) Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat Commun 9(1):251","journal-title":"Nat Commun"},{"issue":"7","key":"9048_CR58","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI23865","volume":"115","author":"C Peyssonnaux","year":"2005","unstructured":"Peyssonnaux C et al (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115(7):1806\u20131815","journal-title":"J Clin Invest"},{"issue":"4","key":"9048_CR59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.it.2011.01.004","volume":"32","author":"MA Cox","year":"2011","unstructured":"Cox MA, Harrington LE, Zajac AJ (2011) Cytokines and the inception of CD8 T cell responses. Trends Immunol 32(4):180\u2013186","journal-title":"Trends Immunol"},{"key":"9048_CR60","volume":"114","author":"Q Deng","year":"2023","unstructured":"Deng Q et al (2023) Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo. Int Immunopharmacol 114:109574","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"9048_CR61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jid.2023.08.006","volume":"144","author":"EJ Lee","year":"2024","unstructured":"Lee EJ et al (2024) ISG15-USP18 dysregulation by oxidative stress promotes IFN-\u03b3 secretion from CD8+ T cells in vitiligo. J Invest Dermatol 144(2):273-283.e11","journal-title":"J Invest Dermatol"},{"issue":"7","key":"9048_CR62","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE et al (2012) A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8\u207a T-cell accumulation in the skin. J Invest Dermatol 132(7):1869\u20131876","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9048_CR63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jdermsci.2024.02.009","volume":"114","author":"J Chen","year":"2024","unstructured":"Chen J et al (2024) Oxidative stress-induced hypermethylation and low expression of ANXA2R: novel insights into the dysfunction of melanocytes in vitiligo. J Dermatol Sci 114(3):115\u2013123","journal-title":"J Dermatol Sci"},{"issue":"10","key":"9048_CR64","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28(10):1057\u20131068","journal-title":"Nat Biotechnol"},{"issue":"1\u20132","key":"9048_CR65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevOncog.2015012997","volume":"20","author":"HP Chen","year":"2015","unstructured":"Chen HP, Zhao YT, Zhao TC (2015) Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog 20(1\u20132):35\u201347","journal-title":"Crit Rev Oncog"},{"issue":"8","key":"9048_CR66","volume":"33","author":"R Liu","year":"2024","unstructured":"Liu R, Zhang L, Zhang K (2024) Histone modification in psoriasis: molecular mechanisms and potential therapeutic targets. Exp Dermatol 33(8):e15151","journal-title":"Exp Dermatol"},{"issue":"5","key":"9048_CR67","first-page":"804","volume":"35","author":"N Hu","year":"2008","unstructured":"Hu N et al (2008) Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 35(5):804\u2013810","journal-title":"J Rheumatol"},{"issue":"2","key":"9048_CR68","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2133.2011.10646.x","volume":"166","author":"M Zhao","year":"2012","unstructured":"Zhao M et al (2012) Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. Br J Dermatol 166(2):226\u2013273","journal-title":"Br J Dermatol"},{"issue":"3","key":"9048_CR69","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jcmm.12206","volume":"18","author":"M Becatti","year":"2014","unstructured":"Becatti M et al (2014) SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival. J Cell Mol Med 18(3):514\u2013529","journal-title":"J Cell Mol Med"},{"issue":"6","key":"9048_CR70","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.7150\/thno.30398","volume":"9","author":"X Yi","year":"2019","unstructured":"Yi X et al (2019) SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo. Theranostics 9(6):1614\u20131633","journal-title":"Theranostics"},{"issue":"12","key":"9048_CR71","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","volume":"187","author":"KE Cole","year":"1998","unstructured":"Cole KE et al (1998) Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187(12):2009\u20132021","journal-title":"J Exp Med"},{"issue":"1","key":"9048_CR72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/bjd.14878","volume":"176","author":"E Lee","year":"2017","unstructured":"Lee E et al (2017) Interferon-inducible T-cell alpha chemoattractant (ITAC) induces the melanocytic migration and hypopigmentation through destabilizing p53 via histone deacetylase 5: a possible role of ITAC in pigment-related disorders. Br J Dermatol 176(1):127\u2013137","journal-title":"Br J Dermatol"},{"issue":"3","key":"9048_CR73","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjd.15199","volume":"177","author":"YC Lai","year":"2017","unstructured":"Lai YC et al (2017) Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol 177(3):708\u2013718","journal-title":"Br J Dermatol"},{"issue":"10","key":"9048_CR74","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamadermatol.2023.2787","volume":"159","author":"K Bibeau","year":"2023","unstructured":"Bibeau K et al (2023) Mental health and psychosocial quality-of-life burden among patients with vitiligo: findings from the Global VALIANT Study. JAMA Dermatol 159(10):1124\u20131128","journal-title":"JAMA Dermatol"},{"issue":"11","key":"9048_CR75","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.3390\/ijms24119130","volume":"24","author":"K Dopytalska","year":"2023","unstructured":"Dopytalska K et al (2023) The essential role of microRNAs in inflammatory and autoimmune skin diseases-a review. Int J Mol Sci 24(11):9130","journal-title":"Int J Mol Sci"},{"key":"9048_CR76","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y et al (2022) The role of microRNA in the inflammatory response of wound healing. Front Immunol 13:852419","journal-title":"Front Immunol"},{"issue":"22","key":"9048_CR77","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.3390\/ijms222212489","volume":"22","author":"H Lee","year":"2021","unstructured":"Lee H, Hong Y, Kim M (2021) Structural and functional changes and possible molecular mechanisms in aged skin. Int J Mol Sci 22(22):12489","journal-title":"Int J Mol Sci"},{"issue":"9","key":"9048_CR78","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.molmed.2024.04.009","volume":"30","author":"Z Mukhatayev","year":"2024","unstructured":"Mukhatayev Z, Le Poole IC (2024) Vitiligo: advances in pathophysiology research and treatment development. Trends Mol Med 30(9):844\u2013862","journal-title":"Trends Mol Med"},{"key":"9048_CR79","first-page":"785","volume":"15","author":"R Zhang","year":"2022","unstructured":"Zhang R et al (2022) Expression profile and bioinformatics analysis of circular RNAs in patients with vitiligo. Pharmgenomics Pers Med 15:785\u2013796","journal-title":"Pharmgenomics Pers Med"},{"issue":"2","key":"9048_CR80","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms24021337","volume":"24","author":"SV Krylova","year":"2023","unstructured":"Krylova SV, Feng D (2023) The machinery of exosomes: biogenesis, release, and uptake. Int J Mol Sci 24(2):1337","journal-title":"Int J Mol Sci"},{"issue":"10","key":"9048_CR81","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jprot.2010.06.006","volume":"73","author":"S Mathivanan","year":"2010","unstructured":"Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73(10):1907\u20131920","journal-title":"J Proteomics"},{"issue":"20","key":"9048_CR82","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1111\/jcmm.15864","volume":"24","author":"C Zhao","year":"2020","unstructured":"Zhao C et al (2020) Down-regulation of exosomal miR-200c derived from keratinocytes in vitiligo lesions suppresses melanogenesis. J Cell Mol Med 24(20):12164\u201312175","journal-title":"J Cell Mol Med"},{"issue":"1","key":"9048_CR83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdermsci.2016.07.003","volume":"84","author":"MS Mansuri","year":"2016","unstructured":"Mansuri MS, Singh M, Begum R (2016) miRNA signatures and transcriptional regulation of their target genes in vitiligo. J Dermatol Sci 84(1):50\u201358","journal-title":"J Dermatol Sci"},{"issue":"6","key":"9048_CR84","first-page":"742","volume":"96","author":"L \u0160ahmatova","year":"2016","unstructured":"\u0160ahmatova L et al (2016) MicroRNA-155 is dysregulated in the skin of patients with vitiligo and inhibits melanogenesis-associated genes in melanocytes and keratinocytes. Acta Derm Venereol 96(6):742\u2013747","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"9048_CR85","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cdd.2015.117","volume":"23","author":"Q Shi","year":"2016","unstructured":"Shi Q et al (2016) Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo. Cell Death Differ 23(3):496\u2013508","journal-title":"Cell Death Differ"},{"issue":"10","key":"9048_CR86","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/1346-8138.13886","volume":"44","author":"Z Shang","year":"2017","unstructured":"Shang Z, Li H (2017) Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients. J Dermatol 44(10):1138\u20131144","journal-title":"J Dermatol"},{"issue":"9","key":"9048_CR87","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jid.2017.06.012","volume":"137","author":"VS Spiegelman","year":"2017","unstructured":"Spiegelman VS, Elcheva IA (2017) Metabo-miR: miR-211 regulates mitochondrial energy metabolism in vitiligo. J Invest Dermatol 137(9):1828\u20131830","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9048_CR88","first-page":"858","volume":"21","author":"X Sun","year":"2020","unstructured":"Sun X et al (2020) \u039cicroRNA-421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor-interacting serine\/threonine kinase 1. Mol Med Rep 21(2):858\u2013866","journal-title":"Mol Med Rep"},{"issue":"2","key":"9048_CR89","volume":"35","author":"Z Zhang","year":"2021","unstructured":"Zhang Z et al (2021) Differentially expressed microRNAs in peripheral blood mononuclear cells of non-segmental vitiligo and their clinical significance. J Clin Lab Anal 35(2):e23648","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"9048_CR90","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jdermsci.2020.10.014","volume":"101","author":"M Aguennouz","year":"2021","unstructured":"Aguennouz M et al (2021) Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes. J Dermatol Sci 101(1):22\u201329","journal-title":"J Dermatol Sci"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09048-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09048-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09048-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T02:05:47Z","timestamp":1744250747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09048-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9048"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09048-z","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"22 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}